Iranian Journal of Pediatrics

Published by: Kowsar

Comparison of Adenosine Deaminase Level in Serum and Synovial Fluid in Patients with Juvenile Idiopathic Arthritis and Its Relation to Inflammatory Acute Phase Reactants

Khosro Rahmani 1 , 2 , Seyed-Reza Raeeskarami 3 , 4 , Vahid Ziaee 3 , 4 , 5 , Payman Sadeghi 4 , * , Mohammad-Hassan Moradinejad 1 , 4 , 5 and Mohammad-Taghi Haghi-Ashtiani 1 , 6
Authors Information
1 Children’s Medical Center, Pediatrics Center of Excellence, Tehran, IR Iran
2 Mofid Children Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
3 Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
4 Department of Pediatrics, Tehran University of Medical Sciences, Tehran, IR Iran
5 Growth and Development Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
6 Department of Pathology, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Pediatrics: December 2017, 27 (6); e9888
  • Published Online: October 16, 2017
  • Article Type: Research Article
  • Received: December 2, 2016
  • Revised: July 6, 2017
  • Accepted: August 7, 2017
  • DOI: 10.5812/ijp.9888

To Cite: Rahmani K, Raeeskarami S, Ziaee V, Sadeghi P, Moradinejad M, et al. Comparison of Adenosine Deaminase Level in Serum and Synovial Fluid in Patients with Juvenile Idiopathic Arthritis and Its Relation to Inflammatory Acute Phase Reactants, Iran J Pediatr. 2017 ;27(6):e9888. doi: 10.5812/ijp.9888.

Abstract
Copyright © 2017, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Davatchi F. Rheumatology in Iran. Int J Rheum Dis. 2009; 12: 283-7
  • 2. Davatchi F, Jamshidi AR, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. J Rheumatol. 2008; 35(7): 1384[PubMed]
  • 3. Davatchi F, Jamshidi AR, Tehrani Banihashemi A, Gholami J, Hossein Forouzanfar M, Akhlaghi M, et al. Effect of ethnic origin (Caucasians versus Turks) on the prevalence of rheumatic diseases: a WHO-ILAR COPCORD urban study in Iran. Clin Rheumatol. 2009; 28(11): 1275-82[DOI][PubMed]
  • 4. Davatchi F, Tehrani Banihashemi A, Gholami J, Faezi ST, Forouzanfar MH, Salesi M, et al. The prevalence of musculoskeletal complaints in a rural area in Iran: a WHO-ILAR COPCORD study (stage 1, rural study) in Iran. Clin Rheumatol. 2009; 28(11): 1267-74[DOI][PubMed]
  • 5. Brasington RD. Rheumatology. 2011; : 829-38
  • 6. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011; 365(23): 2205-19[DOI][PubMed]
  • 7. Appelboom T, Mandelbaum I, Vertongen F. Purine enzyme levels in rheumatoid arthritis. J Rheumatol. 1985; 12(6): 1075-8[PubMed]
  • 8. Samsonov MY, Tilz GP, Egorova O, Reibnegger G, Balabanova RM, Nassonov EL, et al. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus. 1995; 4(1): 29-32[DOI][PubMed]
  • 9. Weinblatt ME, Keystone EC, Cohen MD, Freundlich B, Li J, Chon Y, et al. Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate. J Rheumatol. 2011; 38(2): 242-6[DOI][PubMed]
  • 10. Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA. Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study. J Rheumatol. 2011; 38(1): 44-52[DOI][PubMed]
  • 11. Cylwik B, Chrostek L, Gindzienska-Sieskiewicz E, Sierakowski S, Szmitkowski M. Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis. Adv Med Sci. 2010; 55(1): 80-5[DOI][PubMed]
  • 12. Iwaki-Egawa S, Yamamoto T, Watanabe Y. Human plasma adenosine deaminase 2 is secreted by activated monocytes. Biol Chem. 2006; 387(3): 319-21[DOI][PubMed]
  • 13. Antonioli L, Colucci R, La Motta C, Tuccori M, Awwad O, Da Settimo F, et al. Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Curr Drug Targets. 2012; 13(6): 842-62[PubMed]
  • 14. Nakamachi Y, Koshiba M, Nakazawa T, Hatachi S, Saura R, Kurosaka M, et al. Specific increase in enzymatic activity of adenosine deaminase 1 in rheumatoid synovial fibroblasts. Arthritis Rheum. 2003; 48(3): 668-74[DOI][PubMed]
  • 15. Salesi M, Ghazvini RA, Farajzadegan Z, Karimifar M, Karimzadeh H, Masoumi M, et al. Serum adenosine deaminase in patients with rheumatoid arthritis treated with methotrexate. J Res Pharm Pract. 2012; 1(2): 72-6[DOI][PubMed]
  • 16. Zakeri Z, Izadi S, Niazi A, Bari Z, Zendeboodi S, Shakiba M, et al. Comparison of adenosine deaminase levels in serum and synovial fluid between patients with rheumatoid arthritis and osteoarthritis. Int J Clin Exp Med. 2012; 5(2): 195-200[PubMed]
  • 17. Zamani B, Jamali R, Jamali A. Serum adenosine deaminase may predict disease activity in rheumatoid arthritis. Rheumatol Int. 2012; 32(7): 1967-75[DOI][PubMed]
  • 18. Calis M, Ates F, Yazici C, Kose K, Kirnap M, Demir M, et al. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behcet's disease. Rheumatol Int. 2005; 25(6): 452-6[DOI][PubMed]
  • 19. Sari RA, Taysi S, Yilmaz O, Bakan N. Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol. 2003; 21(1): 87-90[PubMed]
  • 20. Hitoglou S, Hatzistilianou M, Gougoustamou D, Athanassiadou F, Kotsis A, Catriu D. Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2001; 20(6): 411-6[PubMed]
  • 21. Pallinti V, Ganesan N, Anbazhagan M, Rajasekhar G. Serum biochemical markers in rheumatoid arthritis. Indian J Biochem Biophys. 2009; 46(4): 342-4[PubMed]
  • 22. Erer B, Yilmaz G, Yilmaz FM, Koklu S. Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-alpha therapy. Rheumatol Int. 2009; 29(6): 651-4[DOI][PubMed]
  • 23. Krenke R, Korczynski P. Use of pleural fluid levels of adenosine deaminase and interferon gamma in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med. 2010; 16(4): 367-75[DOI][PubMed]
  • 24. Moghtaderi A, Niazi A, Alavi-Naini R, Yaghoobi S, Narouie B. Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis. Clin Neurol Neurosurg. 2010; 112(6): 459-62[DOI][PubMed]
  • 25. Alborzi A, Hosseini-nasab A, Zeyaeian M. A case of hypogammaglobulinemia with enteroviral meningoencephalitis, associated with increased adenosine deaminase in cerebrospinal fluid. Iran J Allergy Asthma Immunol. 2009; 8: 117-9
  • 26. Ziaee V, Amiran A, Moradinejad MH, HaghiAshtiani MT. Evaluation of Serum Adenosine Deaminase Changes Before and After Treatment in Patients with Systemic Lupus Erythematosus, Henoch-Schonlein Purpura and Juvenile Idiopathic Arthritis. Ann Paediatr Rheumatol. 2013; 2(1): 21[DOI]
  • 27. Zamani B, Jamali R, Ehteram H. Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis. Rheumatol Int. 2012; 32(1): 183-8[DOI][PubMed]
  • 28. Currey HLF. Copeman's Textbook of the rheumatic diseases. 1978; : 261-72
  • 29. Guieu R, Dussol B, Halimi G, Bechis G, Sampieri F, Berland Y, et al. Adenosine and the nervous system: pharmacological data and therapeutic perspectives. Gen Pharmacol. 1998; 31(4): 553-61[PubMed]
  • 30. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998; 50(3): 413-92[PubMed]
  • 31. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol. 1997; 79(12A): 2-10[PubMed]
  • 32. Yuksel H, Akoglu TF. Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis. 1988; 47(6): 492-5[PubMed]
  • 33. Doudkani-Fard M, Ziaee V, Moradinejad MH, Sedaghat M, Haghi-Ashtiani MT, Ahmadinejad Z. Sensitivity and specificity of adenosine deaminase in diagnosis of juvenile idiopathic arthritis. Med J Islam Repub Iran. 2014; 28: 113[PubMed]
  • 34. Vinapamula KS, Pemmaraju SV, Bhattaram SK, Bitla AR, Manohar SM. Serum Adenosine Deaminase as Inflammatory Marker in Rheumatoid Arthritis. J Clin Diagn Res. 2015; 9(9)-10[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments